Bibliographic record
Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight…
Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. JAMA 2023
§1Bibliographic record
§1.1Record
- Authors
- Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M
- Title
- Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss
- Source
- JAMA
- Year
- 2023
- Volume, issue, pages
- 330(18):1795–1797
- Digital object identifier
- 10.1001/jama.2023.19574
- PubMed identifier
- 37796527
- Record type
- Journal article
- Institute identifier
- CEI-BR-102
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
| Document | Series |
|---|---|
| Monograph: Semaglutide | Compound monograph |
| Synthesis: Gastrointestinal adverse events with incretin receptor agonists | Evidence synthesis |
| Synthesis: Analytical surveys of unregulated peptide supply | Evidence synthesis |
| Synthesis: Acute pancreatitis with incretin-based therapies | Evidence synthesis |
| 4 citing documents. | |
§1.3Subject tags
glp-1 safety pharmacoepidemiology
Compound Evidence Institute · CEI-BR-102 · https://compoundevidence.com/bibliography/sodhi2023/ · retrieved 30 July 2026